DAEWOONG PHARMACEUTICAL CO.LTD.
Daewoong
Global Healthcare Group
The Best Partner for You
Global Healthcare Group
The Best Partner for You
Plants
Pan-Global Specialized Manufacturing Capabilities
Global Plants
Maximizing our accumulated knowhow,
we have acquired or built plants in strategic
geographical locations that better enable us
to address the local markets' needs.
we have acquired or built plants in strategic
geographical locations that better enable us
to address the local markets' needs.
IndonesiaSurabaya Plant
Surabaya- Feature
- Dedicated for Biological products (EPO, EGF,
Somatropin) - Independent production lines preventing cross-
contamination - HALAL certified process management from drug
substance to finished products - Capacity: Prefilled Syringe (4M)
- Area
- 2,484 m2 (26,737 ft2)
- Manufacturing Products
- Biopharmaceutical Products
(EPO, EGF, hGH, BMP)
ChinaLiaoning Plant
Liaoning- Feature
- Closed system throughout the production process
- BIN System based transfer and handling
- Unmanned ingredient transfer using line and pump
- Capacity: Oral Liquid (200M pouch, 30M bottle)
- Area
- 9,586 m2 (103,182 ft2)
- Manufacturing Products
- Liquid for oral administration
ChinaSichuan Plant
Sichuan- Feature
- Top gall bladder-related production technology
- UDCA intermediate production
- API & CDCA (Chenodeoxycholic acid)
- Area
- 10,000 m2 (107,639 ft2)
- Manufacturing Products
- Chenodeoxycholic acid, crude Cholic acid
Total Capacity per Year
| Type | Quantity |
|---|---|
| Tablet | 6.7 Billion |
| Capsule | 205 Million |
| Vial | 70 Million |
| Bottle | 102 Million |
| Pouch | 130 Million |
| Syringe | 5.6 Million |
| Bag | 0.5 Million |
| Ampoule | 0.1 Billion |
| Kit | 7 Million |